- Home
- LSAK vs AMLX Comparison
LSAK vs AMLX Comparison
Compare LSAK & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- AMLX
- Stock Information
- Founded
- LSAK 1997
- AMLX 2014
- Country
- LSAK South Africa
- AMLX United States
- Employees
- LSAK N/A
- AMLX N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- LSAK Finance
- AMLX Health Care
- Exchange
- LSAK Nasdaq
- AMLX Nasdaq
- Market Cap
- LSAK 408.0M
- AMLX 330.5M
- IPO Year
- LSAK N/A
- AMLX 2022
- Fundamental
- Price
- LSAK $4.74
- AMLX $3.51
- Analyst Decision
- LSAK
- AMLX Buy
- Analyst Count
- LSAK 0
- AMLX 4
- Target Price
- LSAK N/A
- AMLX $7.50
- AVG Volume (30 Days)
- LSAK 31.4K
- AMLX 772.2K
- Earning Date
- LSAK 05-07-2025
- AMLX 05-08-2025
- Dividend Yield
- LSAK N/A
- AMLX N/A
- EPS Growth
- LSAK N/A
- AMLX N/A
- EPS
- LSAK N/A
- AMLX N/A
- Revenue
- LSAK $576,604,000.00
- AMLX $87,371,000.00
- Revenue This Year
- LSAK $0.04
- AMLX N/A
- Revenue Next Year
- LSAK $1.74
- AMLX N/A
- P/E Ratio
- LSAK N/A
- AMLX N/A
- Revenue Growth
- LSAK 5.39
- AMLX N/A
- 52 Week Low
- LSAK $3.83
- AMLX $1.58
- 52 Week High
- LSAK $5.60
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- LSAK 46.38
- AMLX 47.52
- Support Level
- LSAK $4.51
- AMLX $3.23
- Resistance Level
- LSAK $5.10
- AMLX $3.83
- Average True Range (ATR)
- LSAK 0.26
- AMLX 0.26
- MACD
- LSAK 0.01
- AMLX -0.02
- Stochastic Oscillator
- LSAK 51.35
- AMLX 36.36
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.